FABP5 and cancer: A patent entitled “Biomarker compositions and methods (WO 2014082083 A1)” describes a technique to detect cancer-associated EVs in bodily fluids by staining lipid layers of EVs, and various cancer-associated antigens including FABP5 were described as potential microvesicle-associated antigens.